title: Drug transport to brain with targeted nanoparticles.
abstract: Nanoparticle drug carriers consist of solid biodegradable particles in size ranging from 10 to 1000 nm (50-300 nm generally). They cannot freely diffuse through the blood-brain barrier (BBB) and require receptor-mediated transport through brain capillary endothelium to deliver their content into the brain parenchyma. Polysorbate 80-coated polybutylcyanoacrylate nanoparticles can deliver drugs to the brain by a still debated mechanism. Despite interesting results these nanoparticles have limitations, discussed in this review, that may preclude, or at least limit, their potential clinical applications. Long-circulating nanoparticles made of methoxypoly(ethylene glycol)- polylactide or poly(lactide-co-glycolide) (mPEG-PLA/PLGA) have a good safety profiles and provide drug-sustained release. The availability of functionalized PEG-PLA permits to prepare target-specific nanoparticles by conjugation of cell surface ligand. Using peptidomimetic antibodies to BBB transcytosis receptor, brain-targeted pegylated immunonanoparticles can now be synthesized that should make possible the delivery of entrapped actives into the brain parenchyma without inducing BBB permeability alteration. This review presents their general properties (structure, loading capacity, pharmacokinetics) and currently available methods for immunonanoparticle preparation.
authors.affiliation: Faculty of Medicine and Pharmacy, University of Poitiers, 86000 Poitiers, France. Jean.Christophe.Olivier@univ-poitiers.fr
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Olivier
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism*; D016503:Drug Delivery Systems / Q000379:methods*; D005079:Excipients; D006801:Humans; D008863:Microspheres; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010599:Pharmacokinetics; D011092:Polyethylene Glycols / Q000737:chemistry
chemical_list: D005079:Excipients; D004364:Pharmaceutical Preparations; D011092:Polyethylene Glycols
references.citation: Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12754-9
references.pmid: 11592987
references.citation: Biomaterials. 2000 Oct;21(20):2097-101
references.pmid: 10966020
references.citation: Biomaterials. 1993 May;14(6):470-8
references.pmid: 8507795
references.citation: Adv Drug Deliv Rev. 2003 Feb 24;55(3):329-47
references.pmid: 12628320
references.citation: J Control Release. 2002 Apr 23;80(1-3):157-68
references.pmid: 11943395
references.citation: Int J Pharm. 2000 Apr 10;199(1):95-110
references.pmid: 10794931
references.citation: Biomaterials. 1990 Oct;11(8):590-5
references.pmid: 2279061
references.citation: J Pharm Sci. 2004 Jul;93(7):1804-14
references.pmid: 15176068
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7567-72
references.pmid: 10840060
references.citation: Pharm Res. 2004 Feb;21(2):354-64
references.pmid: 15032319
references.citation: Pharm Res. 2000 Oct;17(10):1159-67
references.pmid: 11145219
references.citation: Int J Pharm. 2002 Feb 21;233(1-2):239-52
references.pmid: 11897428
references.citation: FEBS Lett. 1977 Dec 15;84(2):323-6
references.pmid: 598513
references.citation: Pharm Res. 1997 Mar;14(3):325-8
references.pmid: 9098875
references.citation: Drug Deliv. 1996;3(3):187-95
references.pmid: 26790915
references.citation: Vaccine. 2004 Jun 23;22(19):2406-12
references.pmid: 15193402
references.citation: J Biomed Mater Res. 1999 Dec 5;47(3):388-95
references.pmid: 10487891
references.citation: Eur J Pharm Biopharm. 1999 Mar;47(2):119-23
references.pmid: 10234535
references.citation: Eur J Pharm Biopharm. 1998 Jan;45(1):41-8
references.pmid: 9689534
references.citation: Drug Dev Ind Pharm. 2002 Jan;28(1):1-13
references.pmid: 11858519
references.citation: J Control Release. 2001 Jan 29;70(1-2):63-70
references.pmid: 11166408
references.citation: Pharm Res. 1999 Dec;16(12):1836-42
references.pmid: 10644071
references.citation: J Microencapsul. 1998 Jan-Feb;15(1):67-74
references.pmid: 9463808
references.citation: Int J Pharm. 2002 Feb 21;233(1-2):51-9
references.pmid: 11897410
references.citation: Biomaterials. 1997 Feb;18(4):281-8
references.pmid: 9068888
references.citation: Cancer Chemother Pharmacol. 1990;26(1):13-8
references.pmid: 2322986
references.citation: J Control Release. 2002 Jul 18;82(1):105-14
references.pmid: 12106981
references.citation: Biomaterials. 1996 Nov;17(22):2191-7
references.pmid: 8922605
references.citation: Biomaterials. 1996 Aug;17(16):1575-81
references.pmid: 8842361
references.citation: Pharm Dev Technol. 2003;8(2):153-61
references.pmid: 12760566
references.citation: J Control Release. 1999 Mar 29;58(2):143-51
references.pmid: 10053187
references.citation: J Control Release. 2004 Apr 28;96(2):273-83
references.pmid: 15081218
references.citation: J Biomed Mater Res. 1997 Nov;37(2):229-34
references.pmid: 9358316
references.citation: Int J Cancer. 2004 May 1;109(5):759-67
references.pmid: 14999786
references.citation: Adv Drug Deliv Rev. 2002 Jun 17;54(4):459-76
references.pmid: 12052709
references.citation: J Control Release. 2002 Jul 18;82(1):17-27
references.pmid: 12106973
references.citation: J Control Release. 2001 Nov 9;77(1-2):27-38
references.pmid: 11689257
references.citation: J Control Release. 1999 Aug 5;60(2-3):179-88
references.pmid: 10425324
references.citation: Prog Lipid Res. 2003 Nov;42(6):463-78
references.pmid: 14559067
references.citation: J Control Release. 1998 Jan 2;50(1-3):31-40
references.pmid: 9685870
references.citation: J Pharm Sci. 1994 May;83(5):727-32
references.pmid: 8071830
references.citation: Life Sci. 2000;66(6):495-502
references.pmid: 10794066
references.citation: J Gene Med. 2002 Mar-Apr;4(2):183-94
references.pmid: 11933219
references.citation: Colloids Surf B Biointerfaces. 2000 Oct 1;18(3-4):301-313
references.pmid: 10915952
references.citation: Eur J Pharm Sci. 2004 Feb;21(2-3):361-70
references.pmid: 14757510
references.citation: Curr Med Chem. 2004 Feb;11(4):413-24
references.pmid: 14965222
references.citation: Eur J Pharm Biopharm. 2000 Mar;49(2):103-9
references.pmid: 10704892
references.citation: Biol Pharm Bull. 2003 Jan;26(1):116-9
references.pmid: 12520188
references.citation: Int J Pharm. 2004 Jun 18;278(1):133-41
references.pmid: 15158956
references.citation: J Control Release. 1998 Jan 2;50(1-3):21-30
references.pmid: 9685869
references.citation: Pharm Biotechnol. 1997;10:1-43
references.pmid: 9160367
references.citation: Int J Pharm. 2001 Feb 19;214(1-2):31-5
references.pmid: 11282233
references.citation: Pharm Res. 1993 Dec;10(12):1732-7
references.pmid: 7905625
references.citation: Pharm Res. 1990 Jul;7(7):736-41
references.pmid: 2395802
references.citation: Biomaterials. 2003 Nov;24(24):4529-37
references.pmid: 12922162
references.citation: Invest New Drugs. 1992 Aug;10(3):191-9
references.pmid: 1428729
references.citation: Eur J Pharm Sci. 1999 Dec;9(2):163-70
references.pmid: 10620729
references.citation: Pharmacol Rev. 2001 Jun;53(2):283-318
references.pmid: 11356986
references.citation: Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5592-6
references.pmid: 7777554
references.citation: Pharm Res. 2001 Nov;18(11):1613-9
references.pmid: 11758771
references.citation: Pharm Res. 1994 Dec;11(12):1800-8
references.pmid: 7899246
references.citation: Int J Pharm. 1999 Aug 5;185(1):93-101
references.pmid: 10425369
references.citation: FASEB J. 2002 Aug;16(10):1217-26
references.pmid: 12153989
references.citation: Adv Drug Deliv Rev. 2003 Apr 25;55(4):519-48
references.pmid: 12706049
references.citation: J Pharm Sci. 1995 Apr;84(4):493-8
references.pmid: 7629743
references.citation: Pharm Res. 2001 Aug;18(8):1157-66
references.pmid: 11587488
references.citation: Pharm Res. 2002 Aug;19(8):1137-43
references.pmid: 12240939
references.citation: J Control Release. 2001 Jan 29;70(1-2):1-20
references.pmid: 11166403
references.citation: Adv Drug Deliv Rev. 2004 May 7;56(9):1257-72
references.pmid: 15109768
references.citation: Eur J Pharm Biopharm. 2001 Mar;51(2):111-8
references.pmid: 11226817
references.citation: Biomaterials. 2003 Nov;24(24):4475-86
references.pmid: 12922157
references.citation: Biochim Biophys Acta. 2002 Jun 12;1590(1-3):131-9
references.pmid: 12063176
references.citation: Pharm Res. 2003 Nov;20(11):1779-85
references.pmid: 14661922
references.citation: J Control Release. 2001 Jul 10;75(1-2):211-24
references.pmid: 11451511
references.citation: FEBS Lett. 2002 Dec 18;532(3):338-44
references.pmid: 12482589
references.citation: Biomacromolecules. 2002 Jan-Feb;3(1):194-200
references.pmid: 11866573
references.citation: Adv Drug Deliv Rev. 2003 Apr 25;55(4):501-18
references.pmid: 12706048
references.citation: Brain Res. 1995 Mar 13;674(1):171-4
references.pmid: 7773690
references.citation: J Control Release. 1998 Apr 30;53(1-3):85-92
references.pmid: 9741916
references.citation: J Pharm Sci. 1982 Jul;71(7):786-90
references.pmid: 7120063
references.citation: J Biomed Mater Res. 1999;48(3):342-53
references.pmid: 10398040
references.citation: J Control Release. 2004 Jun 18;97(2):291-300
references.pmid: 15196756
references.citation: J Control Release. 2004 Feb 10;94(2-3):323-35
references.pmid: 14744484
references.citation: Pharm Res. 1999 Oct;16(10):1564-9
references.pmid: 10554098
references.citation: Adv Drug Deliv Rev. 1995 Sep;16(2-3):215-233
references.pmid: 25170183
references.citation: Biomaterials. 1997 Dec;18(24):1599-607
references.pmid: 9613807
references.citation: Int J Pharm. 2001 Feb 19;214(1-2):25-30
references.pmid: 11282232
references.citation: J Pharm Pharmacol. 2000 Sep;52(9):1043-7
references.pmid: 11045883
references.citation: Pharm Res. 1998 Feb;15(2):270-5
references.pmid: 9523314
references.citation: Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14164-9
references.pmid: 8943078
references.citation: Biomaterials. 2004 Jun;25(14):2843-9
references.pmid: 14962562
references.citation: Int J Pharm. 2002 Sep 5;244(1-2):105-15
references.pmid: 12204570
references.citation: Int J Pharm. 2002 Jun 4;239(1-2):113-20
references.pmid: 12052696
references.citation: Acta Physiol Pharmacol Bulg. 1994;20(3-4):77-82
references.pmid: 7645407
references.citation: Biomaterials. 1992;13(15):1093-102
references.pmid: 1493193
references.citation: Adv Drug Deliv Rev. 2001 Mar 23;47(1):65-81
references.pmid: 11251246
references.citation: J Control Release. 1999 Feb 1;57(2):171-85
references.pmid: 9971898
references.citation: Drug Dev Ind Pharm. 2002 Oct;28(9):1091-9
references.pmid: 12455468
references.citation: Cancer Chemother Pharmacol. 1985;14(3):238-42
references.pmid: 3995684
references.citation: Colloids Surf B Biointerfaces. 2000 Oct 1;18(3-4):337-346
references.pmid: 10915955
references.citation: J Biomed Mater Res. 1998 Oct;42(1):45-54
references.pmid: 9740006
references.citation: J Control Release. 1999 Jun 28;60(1):121-8
references.pmid: 10370176
references.citation: Science. 1994 Mar 18;263(5153):1600-3
references.pmid: 8128245
references.citation: Pharm Res. 2002 Apr;19(4):403-10
references.pmid: 12033371
references.citation: Biomaterials. 2000 May;21(10):975-80
references.pmid: 10768748
references.citation: Pharm Res. 1999 Aug;16(8):1294-9
references.pmid: 10468034
references.citation: J Control Release. 2001 Apr 2;71(2):203-11
references.pmid: 11274752
references.citation: Int J Pharm. 2001 Jan 5;212(1):1-9
references.pmid: 11165815
references.citation: Biomaterials. 2001 Nov;22(22):2967-79
references.pmid: 11575471
references.citation: Biomacromolecules. 2001 Summer;2(2):575-80
references.pmid: 11749223
references.citation: J Control Release. 1998 Mar 2;52(1-2):53-62
references.pmid: 9685935
references.citation: J Control Release. 2000 Mar 1;65(1-2):221-9
references.pmid: 10699282
references.citation: Crit Rev Ther Drug Carrier Syst. 2002;19(1):73-98
references.pmid: 12046892
references.citation: J Colloid Interface Sci. 2003 Dec 15;268(2):441-7
references.pmid: 14643246
references.citation: J Drug Target. 2001;9(5):361-78
references.pmid: 11770706
references.citation: Eur J Pharm Sci. 2003 Mar;18(3-4):221-9
references.pmid: 12659933
references.citation: Pharm Res. 1999 Jun;16(6):859-66
references.pmid: 10397606
references.citation: Adv Drug Deliv Rev. 1997 Oct 13;28(1):5-24
references.pmid: 10837562
references.citation: Mol Ther. 2003 Jan;7(1):11-8
references.pmid: 12573613
references.citation: J Drug Target. 1995;3(2):159-65
references.pmid: 7496729
references.citation: Cell Transplant. 1999 Jan-Feb;8(1):47-58
references.pmid: 10338275
references.citation: J Drug Target. 2001 Jun;9(3):209-21
references.pmid: 11697206